Background: As little information is available on children with non-classic presentations of Pompe disease, we wished to gain knowledge of specific clinical characteristics and genotypes. We included all patients younger than 18 years, who had been evaluated at the Pompe Center in Rotterdam, the Netherlands, between 1975 and 2012, excluding those with the classic-infantile form. None were treated with enzyme replacement therapy at the time of evaluation. We collected information on first symptoms, diagnosis, use of a wheelchair and/or respirator, and enzyme and mutation analysis and assessed muscle strength, pulmonary function, and cardiac parameters.Results: Thirty-one patients participated. Median age at symptom onset was 2.6 years (range...
Background Late-onset Pompe disease (LOPD) is a rare, hereditary, progressive disorder that is usual...
Objectives: Pompe disease is a progressive metabolic myopathy for which enzyme replacement therapy (...
Objective. Infantile Pompe's disease is a lethal cardiac and muscular disorder. Current developments...
Background: As little information is available on children with non-classic presentations of Pompe d...
Background: As little information is available on children with non-classic presentations of Pomp...
Background: As little information is available on children with non-classic presentations of Pompe d...
Background: Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficien...
BackgroundPompe disease is a lysosomal storage disorder caused by the deficiency of enzyme acid alph...
Background: Due partly to physicians' unawareness, many adults with Pompe disease are diagnosed with...
Background: Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficien...
Background: Due partly to physicians' unawareness, many adults with Pompe disease are diagnosed with...
Pompe disease is a rare autosomal recessive neuromuscular disorder caused by acid α-glucosidase enzy...
textabstractOBJECTIVE: Infantile Pompe's disease is a lethal cardiac and muscular disorder. Current ...
Pompe disease is a metabolic myopathy. Since the first description of the disease in 1932 by J.C. P...
PurposeTo characterize clinical characteristics and genotypes of patients in the ADVANCE study of 40...
Background Late-onset Pompe disease (LOPD) is a rare, hereditary, progressive disorder that is usual...
Objectives: Pompe disease is a progressive metabolic myopathy for which enzyme replacement therapy (...
Objective. Infantile Pompe's disease is a lethal cardiac and muscular disorder. Current developments...
Background: As little information is available on children with non-classic presentations of Pompe d...
Background: As little information is available on children with non-classic presentations of Pomp...
Background: As little information is available on children with non-classic presentations of Pompe d...
Background: Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficien...
BackgroundPompe disease is a lysosomal storage disorder caused by the deficiency of enzyme acid alph...
Background: Due partly to physicians' unawareness, many adults with Pompe disease are diagnosed with...
Background: Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficien...
Background: Due partly to physicians' unawareness, many adults with Pompe disease are diagnosed with...
Pompe disease is a rare autosomal recessive neuromuscular disorder caused by acid α-glucosidase enzy...
textabstractOBJECTIVE: Infantile Pompe's disease is a lethal cardiac and muscular disorder. Current ...
Pompe disease is a metabolic myopathy. Since the first description of the disease in 1932 by J.C. P...
PurposeTo characterize clinical characteristics and genotypes of patients in the ADVANCE study of 40...
Background Late-onset Pompe disease (LOPD) is a rare, hereditary, progressive disorder that is usual...
Objectives: Pompe disease is a progressive metabolic myopathy for which enzyme replacement therapy (...
Objective. Infantile Pompe's disease is a lethal cardiac and muscular disorder. Current developments...